Neutralizing antibodies against HIV – back in the major leagues?
- 21 June 2002
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 14 (4) , 495-502
- https://doi.org/10.1016/s0952-7915(02)00362-x
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Regional Clustering of Shared Neutralization Determinants on Primary Isolates of Clade C Human Immunodeficiency Virus Type 1 from South AfricaJournal of Virology, 2002
- Viral Persistence: HIV's Strategies of Immune System EvasionAnnual Review of Medicine, 2002
- Evidence for a Correlation Between Antibody-Dependent Cellular Cytotoxicity-Mediating Anti-HIV-1 Antibodies and Prognostic Predictors of HIV InfectionJournal of Clinical Immunology, 2001
- Passive Immunity in Prevention and Treatment of Infectious DiseasesClinical Microbiology Reviews, 2000
- Neutralizing Antibody Responses to Human Immunodeficiency Virus Type 1 in Primary Infection and Long‐Term‐Nonprogressive InfectionThe Journal of Infectious Diseases, 1997
- Antibody‐dependent cellular cytotoxicity in HIV infectionsThe FASEB Journal, 1996
- Passive immunotherapy in AIDS: a double-blind randomized study based on transfusions of plasma rich in anti-human immunodeficiency virus 1 antibodies vs. transfusions of seronegative plasma.Proceedings of the National Academy of Sciences, 1995
- Passive hyperimmune plasma therapy in the treatment of acquired immunodeficiency syndrome: results of a 12-month multicenter double- blind controlled trial. The Passive Hyperimmune Therapy Study Group [see comments]Blood, 1994
- Prevention of HIV Infection by Passive Immunization with HIV ImmunoglobulinAIDS Research and Human Retroviruses, 1991
- Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeysNature, 1991